Similar articles

• Assessment of drugs in schizophrenia. Assessment of psychiatric and social state. 20V.

  Leff J. Leff J. Br J Clin Pharmacol. 1976 Jun;3(3 Suppl 2):385-90. Br J Clin Pharmacol. 1976. PMID: 987793 Free PMC article. No abstract available.
• [Assessment of the severity of psychiatric states].

  Heimann H, Schmocker A. Heimann H, et al. Arzneimittelforschung. 1974 Jul;24(7):1004-6. Arzneimittelforschung. 1974. PMID: 4603350 Clinical Trial. German. No abstract available.
• Oxypertine in the treatment of schizophrenia.

  Alapin B, Golebiewska M. Alapin B, et al. Act Nerv Super (Praha). 1967 Nov;9(4):436-9. Act Nerv Super (Praha). 1967. PMID: 4889080 Clinical Trial. No abstract available.
• A transcultural study with clomacran: comparison of two assessment methods.

  Ban TA, Lehmann HE, Galvan L, Pecknold JC, Climan M. Ban TA, et al. Curr Ther Res Clin Exp. 1974 Sep;16(9):971-89. Curr Ther Res Clin Exp. 1974. PMID: 4214672 Clinical Trial. No abstract available.
• Niacin in the long-term treatment of schizophrenia.

  Wittenborn JR, Weber ES, Brown M. Wittenborn JR, et al. Arch Gen Psychiatry. 1973 Mar;28(3):308-15. doi: 10.1001/archpsyc.1973.01750330010002. Arch Gen Psychiatry. 1973. PMID: 4569673 Clinical Trial. No abstract available.